Screening/Prevention
Mammography Can Measure Growth Rate of Breast Cancer Tumor
(05/12/2008)
New research indicates that screening mammography may provide estimates of breast cancer tumor growth rates. These findings from the Norwegian Breast Cancer Screening Program were recently published in Breast Cancer Research.
Regular Aspirin Use May Reduce Risk of Hormone-positive Breast Cancer
(04/30/2008)
Regular use of aspirin may modestly reduce the risk of developing hormone-positive breast cancer. These results were recently published online by Breast Cancer Research.
Elderly Women Benefit from Screening Mammography
(04/30/2008)
Regular mammograms among women 80 years of age and older may detect earlier stages of breast cancer. These findings were released in an early online publication of the Journal of Clinical Oncology.
Certain Foods May Reduce Risk of Breast Cancer
(04/25/2008)
Further evidence has emerged that certain dietary patterns may help prevent breast cancer among both women with a genetic risk for the disease and those with no genetic risk. These findings were recently published in the Journal of Cancer Detection and Prevention.
Women Share Breast and Ovarian Cancer Testing Results with Family Members
(04/25/2008)
Women who undergo testing for genetic breast cancer are more likely to share the results with other female family members, including children and their siblings, if they are aware of their relative’s opinion of genetic testing. These findings were recently published in the Journal of Family Psychology.
More...
Carcinoma In Situ
Specific Gene Mutations May Affect Response to Tamoxifen in Breast Cancer
(05/06/2008)
Mutations within the CYP2D6 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). These results were recently published in the Journal of the National Cancer Institute.
MammoSite® Shows Promise for Early-stage Breast Cancer Treatment
(02/19/2008)
MammoSite®, a delivery system for partial breast irradiation, appears to be an effective treatment for early-stage breast cancer. These findings were recently published in the journal Cancer.
Women with DCIS Breast Cancer Uncertain About Risk of Recurrence
(02/19/2008)
Women diagnosed with ductal carcinoma in situ (DCIS), the earliest stage of breast cancer, tend to have inaccurate views on their risks of recurrence following treatment. These results were recently published in the Journal of the National Cancer Institute.
Large Majority of Breast Cancer Information on Internet Is Accurate
(02/11/2008)
Approximately 95% of information about breast cancer that is found on the Internet is accurate. These results were recently published in the journal Cancer.
Women with Family History of Breast or Ovarian Cancer Have Increased Risk of Developing Leukemia
(11/12/2007)
According to an article recently published in the International Journal of Cancer, women with breast cancer who have a family history of breast or ovarian cancer have an increased risk of subsequently developing chronic leukemia.
More...
Stage I Node Negative
Mammography Can Measure Growth Rate of Breast Cancer Tumor
(05/12/2008)
New research indicates that screening mammography may provide estimates of breast cancer tumor growth rates. These findings from the Norwegian Breast Cancer Screening Program were recently published in Breast Cancer Research.
Specific Gene Mutations May Affect Response to Tamoxifen in Breast Cancer
(05/06/2008)
Mutations within the CYP2D6 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). These results were recently published in the Journal of the National Cancer Institute.
Vaccine E75 May Improve Survival for Some HER2 Breast Cancer Patients
(04/18/2008)
The investigative vaccine E75 may have survival benefits for patients with breast cancer that has low expression of the human epidermal growth factor receptor 2 (HER2). These results were recently presented at the 2008 annual meeting of the American Association for Cancer Research.
Weekly Taxol® Improves Survival in Early Breast Cancer
(04/17/2008)
The chemotherapy schedule that includes once-weekly administration of Taxol® (paclitaxel) in combination with Adriamycin® (doxorubicin) and Cytoxan® (cyclophosphamide) appears most effective in early breast cancer. These results were recently published in the New England Journal of Medicine.
Chemotherapy-induced Anemia Associated with Breast Cancer Recurrence
(04/10/2008)
A recent study conducted in Austria reveals that in premenopausal women with localized breast cancer, chemotherapy-induced anemia is associated with local recurrence following treatment. Full details of this study were published in the April issue of Clinical Cancer Research.
More...
Stages II-III
Mammography Can Measure Growth Rate of Breast Cancer Tumor
(05/12/2008)
New research indicates that screening mammography may provide estimates of breast cancer tumor growth rates. These findings from the Norwegian Breast Cancer Screening Program were recently published in Breast Cancer Research.
Specific Gene Mutations May Affect Response to Tamoxifen in Breast Cancer
(05/06/2008)
Mutations within the CYP2D6 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). These results were recently published in the Journal of the National Cancer Institute.
Vaccine E75 May Improve Survival for Some HER2 Breast Cancer Patients
(04/18/2008)
The investigative vaccine E75 may have survival benefits for patients with breast cancer that has low expression of the human epidermal growth factor receptor 2 (HER2). These results were recently presented at the 2008 annual meeting of the American Association for Cancer Research.
Weekly Taxol® Improves Survival in Early Breast Cancer
(04/17/2008)
The chemotherapy schedule that includes once-weekly administration of Taxol® (paclitaxel) in combination with Adriamycin® (doxorubicin) and Cytoxan® (cyclophosphamide) appears most effective in early breast cancer. These results were recently published in the New England Journal of Medicine.
Chemotherapy-induced Anemia Associated with Breast Cancer Recurrence
(04/10/2008)
A recent study conducted in Austria reveals that in premenopausal women with localized breast cancer, chemotherapy-induced anemia is associated with local recurrence following treatment. Full details of this study were published in the April issue of Clinical Cancer Research.
More...
Inflammatory
Specific Gene Mutations May Affect Response to Tamoxifen in Breast Cancer
(05/06/2008)
Mutations within the CYP2D6 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). These results were recently published in the Journal of the National Cancer Institute.
Large Majority of Breast Cancer Information on Internet Is Accurate
(02/11/2008)
Approximately 95% of information about breast cancer that is found on the Internet is accurate. These results were recently published in the journal Cancer.
Women with Family History of Breast or Ovarian Cancer Have Increased Risk of Developing Leukemia
(11/12/2007)
According to an article recently published in the International Journal of Cancer, women with breast cancer who have a family history of breast or ovarian cancer have an increased risk of subsequently developing chronic leukemia.
Exercise Improves Quality of Life in Women with Breast Cancer
(05/24/2007)
According to the results of a study published in the Journal of Clinical Oncology, participation in an eight-week program of supervised aerobic exercise significantly improved the quality of life of women who had been treated for breast cancer.
Mitoxantrone-based Therapy Increases Risk for Subsequent Leukemia or Myelodysplastic Syndrome in Breast Cancer Patients
(01/12/2007)
According to an early online publication from the Journal of Clinical Oncology, the use of the chemotherapy agent Novantrone® (mitoxantrone) to treat breast cancer appears to increase the risk of developing acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) later in life.
More...
Metastatic
Blood Test to Detect Tumor Cells May Predict Outcome in Advanced Breast Cancer
(04/03/2008)
Tumor cells in circulating blood may accurately indicate prognosis and tumor response to treatment for patients with metastatic breast cancer, whereas measures of tumors circulating in bone marrow do not. These findings were recently published in the Annals of Oncology.
Women&Cancer Magazine Features Paula Zahn on Spring 2008 Cover
(03/17/2008)
News anchor and cancer advocate Paula Zahn knows what it means to watch a loved one confront a cancer diagnosis. In fact, in the space of 14 months when Paula was 29 years old, her immediate family managed four active cases of cancer; of those four, which included her mother, her father, her sister-in-law and her aunt, only her mother would survive. “I think any of us who have been exposed to cancer in our families share a strong bond,” Paula says. The veteran reporter and media personality shares details of her own experience and of her role as an impassioned cancer advocate in an inspiring interview.
Triple-negative Breast Cancers More Likely to Spread to Brain
(02/29/2008)
Women with triple-negative breast cancer (estrogen receptor-, progesterone receptor-, and human epidermal receptor-negative) have a higher risk that cancer will spread to the brain. These results were recently published in the journal Breast Cancer Research.
Avastin® Approved for Advanced Breast Cancer
(02/26/2008)
The United States Food and Drug Administration (FDA) has granted accelerated approval to Avastin® (bevacizumab) used in combination with Taxol® (paclitaxel) for the treatment of advanced breast cancer.
Addition of Avastin® to Chemotherapy Improves Progression-free Survival in Advanced Breast Cancer
(02/14/2008)
The addition of Avastin® (bevacizumab) to the chemotherapy agent Taxotere® (docetaxel) improves progression-free survival in patients with advanced breast cancer. These results were recently published in a press release by Genentech.
More...
Recurrent
Women&Cancer Magazine Features Paula Zahn on Spring 2008 Cover
(03/17/2008)
News anchor and cancer advocate Paula Zahn knows what it means to watch a loved one confront a cancer diagnosis. In fact, in the space of 14 months when Paula was 29 years old, her immediate family managed four active cases of cancer; of those four, which included her mother, her father, her sister-in-law and her aunt, only her mother would survive. “I think any of us who have been exposed to cancer in our families share a strong bond,” Paula says. The veteran reporter and media personality shares details of her own experience and of her role as an impassioned cancer advocate in an inspiring interview.
Large Majority of Breast Cancer Information on Internet Is Accurate
(02/11/2008)
Approximately 95% of information about breast cancer that is found on the Internet is accurate. These results were recently published in the journal Cancer.
Omnitarg™ plus Herceptin® Effective for Metastatic Breast Cancer
(01/21/2008)
According to results recently presented at the 2007 annual San Antonio Breast Cancer Symposium, the combination of Omnitarg™ (pertuzumab) plus Herceptin® (trastuzumab) provides significant anticancer activity among women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer whose disease had progressed while on therapy with Herceptin alone.
Herceptin® After Cancer Spread to Brain Improves Survival in Breast Cancer
(01/08/2008)
According to results recently presented at the 2007 annual San Antonio Breast Cancer Symposium, treatment with Herceptin® (trastuzumab) after cancer has spread to the brain improves survival for breast cancer patients.
Tykerb® plus Xeloda® Shows Benefits Against Brain Metastases
(12/19/2007)
According to the results of a study presented at the 2007 San Antonio Breast Cancer Symposium (SABCS), the targeted agent Tykerb® (lapatinib), used in combination with the chemotherapy drug Xeloda® (capecitabine), reduces the size of brain metastases in some women with previously-treated HER2-positive breast cancer.
More...
Supportive Care
Changes in Lifestlye May Improve Quality of Life for Breast Cancer Survivors
(05/02/2008)
A recent study conducted by the American Cancer Society reports that although few cancer survivors are following recommendations for lifestyle changes aimed to improve health and well-being, adhering to these guidelines may improve quality of life among breast cancer survivors. Full details of the study were recently published in the Journal of Clinical Oncology.
Women&Cancer Magazine Features Paula Zahn on Spring 2008 Cover
(03/17/2008)
News anchor and cancer advocate Paula Zahn knows what it means to watch a loved one confront a cancer diagnosis. In fact, in the space of 14 months when Paula was 29 years old, her immediate family managed four active cases of cancer; of those four, which included her mother, her father, her sister-in-law and her aunt, only her mother would survive. “I think any of us who have been exposed to cancer in our families share a strong bond,” Paula says. The veteran reporter and media personality shares details of her own experience and of her role as an impassioned cancer advocate in an inspiring interview.
Large Majority of Breast Cancer Information on Internet Is Accurate
(02/11/2008)
Approximately 95% of information about breast cancer that is found on the Internet is accurate. These results were recently published in the journal Cancer.
Effexor® More Effective than Catapres® for Treatment of Hot Flashes in Breast Cancer Patients
(04/09/2007)
According to an article published in the Annals of Oncology, the antidepressive agent Effexor® (venlafaxine) is more effective than Catapres® (clonidine) for the treatment of hot flashes in women with breast cancer.
Breast Cancer Survivors Face Elevated Risk of Suicide
(10/13/2006)
Although few breast cancer survivors commit suicide, the probability of suicide among breast cancer survivors appears to be higher than among women in the general population. These results were published in the Journal of the National Cancer Institute.
More...